PsychU

Employer Role In Employee Mental Health & Wellness
2021-07-21 12:00 - 13:00 (America/New_York) | MO
Home

Events

Employer Role in Employee Mental Health and Wellness

Employers are a driving force in the healthcare system, with nearly half of Americans receiving their benefits through employer-sponsored health plans. One in five adults experiences a mental illness in any given year, and high rates of depression, which can lead to disability and unemployment, and are common in the workplace. The need to increase employee retention while decreasing presenteeism and absenteeism provides employers with incentive to support employee mental health and wellness. Incorporating a healthy workplace culture, accessible insurance benefits, and the mental health and wellness programs are fundamental to fostering a workplace supportive of mental health.

Nationally recognized psychiatrists Dr. Ken Duckworth, Chief Medical Officer at NAMI, and Dr. Don Fowls, managed care expert and healthcare consultant, have worked with leading employers and employer groups across the country. In this exciting panel discussion, Dr. Ken Duckworth and Dr. Don Fowls will discuss the role of employers in the healthcare landscape as well as the impact and opportunities for employers on employee mental health and wellness.

Click here to register for the 3:00 pm ET Broadcast

Ken Duckworth, MDChief Medical Officer, National Association for Mental Illness

Ken Duckworth’s journey into psychiatry started when he was a boy growing up with a dad who experienced severe bipolar disorder. His father was loving, kind and periodically quite ill, hospitalized for months at a time. Ken became a psychiatrist in part to help his father. He is very fortunate to serve as the medical director for NAMI and to be part of this remarkable community.

Along with his work at NAMI, Ken also works to improve care at Blue Cross Blue Shield of Massachusetts, volunteers and consults at an early psychosis clinic at the Massachusetts Mental Health Center and teaches as an assistant clinical professor at Harvard University Medical School.

Ken is double-board certified in adult and child/adolescent psychiatry and has completed a forensic psychiatry fellowship.

Don Fowls, MDPresident, Don Fowls and Associates

Don Fowls, MD is a nationally known psychiatrist and health care consultant who works with organizations across the country, including health plans, employers, health systems and providers, to develop solutions for the many challenges they face today, including access to care, integration, value-based reimbursement, and strategic partnerships. He has also advised several start-up companies regarding strategic, product and business development. Dr. Fowls previously served as Chief Medical Officer and Executive Vice President of Business Development for Value Options and its parent company FHC Health Systems for eleven years. He also worked at Schaller Anderson Inc. as Executive Vice President, Business Development, and President and CEO of its behavioral health subsidiary. Dr. Fowls has served on several boards, including Chairman of the Board for Copa Health in AZ and is past President of the Arizona Psychiatric Society.

Tara McKinley, PharmDManaged Market Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.

Featuring

Ken Duckworth, MD
Chief Medical Officer, National Association for Mental Illness

Don C. Fowls, MD
Psychiatrist and Health Care Consultant

Tara McKinley, PharmD (OPDC)
Managed Market Liaison

Dr. Duckworth is an employee of NAMI, which receives funding from Otsuka Pharmaceutical Development & Commercialization, Inc. Dr. Fowls is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. Tara McKinley is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Please note: Due to high levels of interest, please access this webinar via your computer.

Register

This event registration is closed.

Employer Role In Employee Mental Health & Wellness
2021-07-21 15:00 - 16:00 (America/New_York) | MO
Home

Events

Employer Role in Employee Mental Health and Wellness

Employers are a driving force in the healthcare system, with nearly half of Americans receiving their benefits through employer-sponsored health plans. One in five adults experiences a mental illness in any given year, and high rates of depression, which can lead to disability and unemployment, and are common in the workplace. The need to increase employee retention while decreasing presenteeism and absenteeism provides employers with incentive to support employee mental health and wellness. Incorporating a healthy workplace culture, accessible insurance benefits, and the mental health and wellness programs are fundamental to fostering a workplace supportive of mental health.

Nationally recognized psychiatrists Dr. Ken Duckworth, Chief Medical Officer at NAMI, and Dr. Don Fowls, managed care expert and healthcare consultant, have worked with leading employers and employer groups across the country. In this exciting panel discussion, Dr. Ken Duckworth and Dr. Don Fowls will discuss the role of employers in the healthcare landscape as well as the impact and opportunities for employers on employee mental health and wellness.

Click here to register for the 12:00 pm ET Broadcast

Ken Duckworth, MDChief Medical Officer, National Association for Mental Illness

Ken Duckworth’s journey into psychiatry started when he was a boy growing up with a dad who experienced severe bipolar disorder. His father was loving, kind and periodically quite ill, hospitalized for months at a time. Ken became a psychiatrist in part to help his father. He is very fortunate to serve as the medical director for NAMI and to be part of this remarkable community.

Along with his work at NAMI, Ken also works to improve care at Blue Cross Blue Shield of Massachusetts, volunteers and consults at an early psychosis clinic at the Massachusetts Mental Health Center and teaches as an assistant clinical professor at Harvard University Medical School.

Ken is double-board certified in adult and child/adolescent psychiatry and has completed a forensic psychiatry fellowship.

Don Fowls, MDPresident, Don Fowls and Associates

Don Fowls, MD is a nationally known psychiatrist and health care consultant who works with organizations across the country, including health plans, employers, health systems and providers, to develop solutions for the many challenges they face today, including access to care, integration, value-based reimbursement, and strategic partnerships. He has also advised several start-up companies regarding strategic, product and business development. Dr. Fowls previously served as Chief Medical Officer and Executive Vice President of Business Development for Value Options and its parent company FHC Health Systems for eleven years. He also worked at Schaller Anderson Inc. as Executive Vice President, Business Development, and President and CEO of its behavioral health subsidiary. Dr. Fowls has served on several boards, including Chairman of the Board for Copa Health in AZ and is past President of the Arizona Psychiatric Society.

Tara McKinley, PharmDManaged Market Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.

Featuring

Ken Duckworth, MD
Chief Medical Officer, National Association for Mental Illness

Don C. Fowls, MD
Psychiatrist and Health Care Consultant

Tara McKinley, PharmD (OPDC)
Managed Market Liaison

Dr. Duckworth is an employee of NAMI, which receives funding from Otsuka Pharmaceutical Development & Commercialization, Inc. Dr. Fowls is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. Dr. Tara McKinley is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Please note: Due to high levels of interest, please access this webinar via your computer.

Register

This event registration is closed.

LIVE EVENT - Managing Mental Health During and in the Aftermath of Pandemic
2021-07-21 18:30 - 20:30 (America/New_York) | Stoney River Steakhouse-Duluth, 5800 State Bridge Rd, Duluth, GA, 30097, United States
Home

Events

Managing Mental Health During and in the Aftermath of Pandemic

This is a private event for the UAPRN-Gwinnett Forsyth Chapter members only.

The presentation brings to light the dynamic impact of a pandemic on mental health on healthcare professionals. The discussion examines the dynamic emotional phases of disaster response and the multifaceted contributors to stress on a stress continuum model. Strategies to maintain wellness, build resilience, and engage in healthy-self care will be featured.

Venue

Featuring

Walter Lawhorn, PharmD (OPDC)
Regional Medical Lead

Speaker Walter Lawhorn, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

LIVE EVENT - Sleep Impairment in Psychiatric Disorders
2021-07-22 18:00 - 20:00 (America/New_York) | 91 Wood Fire Oven, 1983 East Maple ST., North Canton, OH, 44720, United States
Home

Events

Sleep Impairment in Psychiatric Disorders

This is a private event for members of Ohio Association of Advanced Practices Nurses (OAAPN).

This presentation provides an overview of sleep impairment in psychiatric disorders. During this event, attendees will learn about:

Chronobiology of SleepSleep Pathology & Economic ImpactDiagnostic MeasurementsSleep Impairment in Psychiatric Disorders:Sleep Medicine Therapeutics

Venue

Featuring

Elizabeth DiNapoli, PhD (OPDC)
Senior Medical Science Liaison

Elizabeth DiNapoli, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

Virtual Event - Management Of Major Depressive Disorder: Breaking Through The Barrier
2021-07-26 15:00 - 16:00 (America/New_York) | MO
Home

Events

Virtual Event – Management Of Major Depressive Disorder: Breaking Through The Barrier

An estimated 1 in 10 US adults report depression, with major depressive disorder (MDD) as common as diabetes or coronary artery disease. During this virtual event, Sanjai Rao, MD, Associate Clinical Professor and Associate Residency Training Director, University of California, San Diego, CA; and Sucharita Somkuwar, PhD, BPharm, Medical Science Liaison, OPDC, discuss how MDD contributes to decreased overall patient health and quality of life, the effect of inadequate treatment response on patients and their families, and the importance of proactive management decisions.

The learning objectives are:

Introduction to MDD and the associated decreased patient health and quality of lifeUnderstanding inadequate treatment response and predictors of inadequate responseProactive treatment

Featuring

Sanjai Rao, MD
Associate Clinical Professor of Psychiatry and Associate Residency Training Director, University of California, San Diego (UCSD); Site Director for Residency Training, VA Medical Center in San Diego, CA

Sucharita Somkuwar, PhD, BPharm (OPDC)
Clinical & Scientific Liaison

Sanjai Rao, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.
Sucharita Somkuwar, PhD, BPharm is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Mental Illness & Substance Use Disorder
2021-08-03 12:00 - 13:00 (America/New_York) | MO
Home

Events

Virtual Event – Mental Illness & Substance Use Disorder

A regional virtual event for PsychU members in CT, DE, MA, ME, NH, RI, VT, Lower Manhattan, Long Island, & Eastern PA.

The prevalence of co-occurring substance use disorders (SUDs) with mental illness remains high. This presentation examines their clinical impact on outcomes, the changing landscape of drugs of abuse, and potential treatment considerations.

Featuring

Stephen Murray, PharmD, MBA (OPDC)
Regional Medical Lead

Alyssa Peckham, PharmD, BCPP (OPDC)
Clinical & Scientific Liaison

Mark Tacelosky, PharmD
Senior Medical Science Liaison

Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

TEST EVENT ONLY
2021-08-03 16:30 - 17:30 (America/New_York) | MO
Home

Events

Test Event Only

This is a test event only. The sole purpose of this event is to use it for testing emails and other issues which need to be addressed on real events. Thank you for your patience.

Featuring

David Block, MD, MMM, FAPA
Clinical Assistant Professor of Psychiatry, Western University of Health Sciences, Loma Linda University and California University of Health and Medicine; Private Practitioner, Costa Mesa, CA

Chet Robachinski, MD
Psychiatric Director, Bailey-Boushay House, Seattle, WA; Founding Partner, Associates in Behavioral Health

Rakesh Jain, MD, MPH
Co-founder of WILD-5 Wellness®

Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Transforming Mental Health Care In The US: A Discussion On The RAND Corporation Report
2021-08-04 12:00 - 13:00 (America/New_York) | MO
Home

Events

Transforming Mental Health Care In The US: A Discussion On The RAND Corporation Report

The United States is at a time of promise for historic transformation in mental health care. For decades, systemic problems have persisted — including high levels of unmet need, underdevelopment of community-based supports, and inequities in access and quality of care. 1In 2019, while nearly one in five Americans had a mental illness, only 45 percent of those people received any mental health treatment. This translates to unmet need for more than 30 million Americans. Additionally, despite similar levels of mental health care need, racial/ethnic minorities in the United States are about half as likely to use mental health care as non-Hispanic Whites. There are also striking geographic variations in availability of mental health specialty care, with rural areas particularly underserved.

The report, sponsored by Otsuka America, Inc., provides recommendations to promote transformational change to improve the lives of the millions of Americans living with mental illness. To identify these recommendations, the authors conducted a broad review of policy ideas related to goals for the mental health system. They conducted an extensive analysis of mental health systems processes, policies, and solutions supported by evidence and received input from experts around the country.

In this webinar, we will review and discuss the findings and recommendations of the report in a lively conversational question and answer format.

Don C. Fowls, MDDon Fowls, MD is a nationally known psychiatrist and health care consultant who works with organizations across the country, including health plans, health systems and providers, to develop solutions for the many challenges they face today, including access to care, integration, value-based reimbursement, and strategic partnerships. He has also advised several start-up companies with regard to strategic, product and business development. Dr Fowls previously served as Chief Medical Officer and Executive Vice President of Business Development for Value Options and its parent company FHC Health Systems for eleven years. He also worked at Schaller Anderson Inc. as Executive Vice President, Business Development, and President and CEO of its behavioral health subsidiary. Dr Fowls has served on several boards, including Chairman of the Board for Copa Health in AZ. He is also recent past President of the Arizona Psychiatric Society.

Tara McKinley, PharmD, Managed Market Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.

1RAND Corporation. How to Transform the U.S. Mental Health System. 2021. Retrieved from https://www.rand.org/pubs/research_reports/RRA889-1.html

Featuring

Don C. Fowls, MD
Psychiatrist and Health Care Consultant

Tara McKinley, PharmD (OPDC)
Managed Market Liaison

Dr. Fowls is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. Tara McKinley, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Please note: Due to high levels of interest, please access this webinar via your computer.

Register

This event registration is closed.

Virtual Event - Do Inflammation & Metabolic Disturbances Metastasize To The Brain? Implications For Disease Modeling & Novel Approaches In Psychiatry
2021-08-09 15:00 - 16:00 (America/New_York) | MO
Home

Events

Virtual Event – Do Inflammation & Metabolic Disturbances Metastasize To The Brain? Implications For Disease Modeling & Novel Approaches In Psychiatry

During this webinar, Dr. David Block, MD, MMM and Sucharita Somkuwar, PhD will discuss the effects of inflammation and metabolic disturbances on mood disorders in a national Virtual Event.

The objectives of the presentation are to:

• Describe the importance of cognitive symptoms as psychiatric targets

• Review immune and metabolic systems associated with cognitive deficits and mood disorders

• Discuss innovative approaches that may target these symptoms

Featuring

David Block, MD, MMM, FAPA
Clinical Assistant Professor of Psychiatry, Western University of Health Sciences, Loma Linda University and California University of Health and Medicine; Private Practitioner, Costa Mesa, CA

Sucharita Somkuwar, PhD, BPharm (OPDC)
Clinical & Scientific Liaison

David Block, MD, MMM is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.
Sucharita Somkuwar, PhD, BPharm is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder
2021-08-12 12:00 - 13:00 (America/New_York) | MO
Home

Events

Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder

Nonadherence is a serious problem that can compromise treatment effectiveness in psychiatry. This presentation will review the multidimensional factors that contribute to adherence, discuss consequences of poor adherence, and bring to light implementation strategies to address adherence.

Featuring

Larry Reccoppa, MD
Regional Psychiatric Director, Wellpath; Staff Psychiatrist, Behavioral Health Services CMHC

Jacquelyn Canning, PharmD, BCPP (OPDC)
Clinical & Scientific Liaison

Aneta Fornal, PharmD (OPDC)
Medical Science Liaison

Speaker Larry Reccoppa, MD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speakers Jacquelyn Canning, PharmD, BCPP and Aneta Fornal, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Mindfulness Meditation In Mental Health
2021-08-24 12:00 - 13:00 (America/New_York) | MO
Home

Events

Virtual Event – Mindfulness Meditation In Mental Health

This is a Virtual Event for PsychU members in DC, MD, NC, and VA.

In this presentation, the objectives are to:

-Provide a brief overview of mindfulness meditation, including the methods and techniques used in mindfulness meditation-Review the evidence on the effectiveness of mindfulness-based interventions for mental health disorders-Discuss potential mechanisms of action

Featuring

Dennis Sholler, PhD (OPDC)
Senior Medical Science Liaison, CNS

Amica Simmons-Yon, PharmD, PhD
Senior Medical Science Liaison, Neuroscience Field Medical Affairs

Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Behavioral Health HEDIS® Measures: An Annual Update From NCQA©
2021-08-25 12:00 - 13:00 (America/New_York) | MO
Home

Events

Behavioral Health HEDIS® Measures: An Annual Update From NCQA©

The National Committee for Quality Assurance (NCQA) collects information on the performance of health care service delivery from health plans covering more than 191 million people using its proprietary Healthcare Effectiveness Data and Information Set, or HEDIS. One of health care’s most widely used performance improvement tools, HEDIS consists of more than 90 measures over six domains of care. In the behavioral health realm, HEDIS assesses depression screening and follow-up, medication adherence, access, care coordination, opioid overuse, and more.1 Join NCQA speaker Lyndsey Nguyen as she provides an update on HEDIS behavioral health measures and reviews changes for measurement year 2022.

Featuring

Lyndsey Nguyen currently serves as a Senior Health Care Analyst in the Performance Measurement Department at the National Committee for Quality Assurance (NCQA). She manages, leads, and coordinates activities related to the development of quality metrics for U.S. health care. Her areas of focus include mental health, substance use, and pain management. Ms. Nguyen holds an M.S. degree in physiology (complementary and alternative medicine) from Georgetown University, and a B.A. in cognitive science from the University of Virginia.Tara McKinley, PharmD, is a Managed Market Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc.

1 HEDIS. (2021, July 15). Retrieved from https://www.ncqa.org/hedis/.

Featuring

Lyndsey Nguyen, MS, BA
Senior Health Care Analyst National Committee for Quality Assurance (NCQA)

Tara McKinley, PharmD (OPDC)
Managed Market Liaison

Lyndsey Nguyen, MS, BA, is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
Tara McKinley, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Inadequately Treated Major Depressive Disorder
2021-08-26 13:00 - 14:00 (America/New_York) | MO
Home

Events

Virtual Event – Inadequately Treated Major Depressive Disorder

This is a Virtual Event for PsychU members in Alabama, Mississippi, and Tennessee.

The presentation highlights the importance of addressing inadequately treated major depressive disorder (MDD). The discussion will feature the prevalence and burden of inadequately treated MDD in the U.S., how inadequate treatment impacts long-term outcomes of MDD and possible treatment strategies.

Featuring

Jason Carter, PharmD
Senior Medical Science Liaison, Neuroscience Field Medical Affairs

Beau Pender, PharmD
Medical Science Liaison

Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Mental Health Awareness: A Focus on Suicide & Stigma
2021-08-31 12:00 - 13:00 (America/New_York) | MO
Home

Events

Mental Health Awareness: A Focus on Suicide & Stigma

This is a Virtual Event for PsychU members in NJ, Upper Manhattan and Rockland County, NY.

The presentation aims to raise mental health awareness on suicide. The discussion will review the multifaceted and dynamic factors that contribute to risk and explore prevention strategies focused on reducing stigma and discrimination.

Featuring

Michael Townsend, MA, LSW/LCSW
Deputy Chief Executive Officer, Gateway Counseling Center

Jehan Marino, PharmD, BCPP
Medical Science Director

Becky Wong, PharmD, MBA
Medical Science Director

Speaker Michael Townsend, MA, LCSW is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.

Speakers Jehan Marino, PharmD, BCPP and Becky Wong, PharmD, MBA are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Proposed Roles Of Modulating Norepinephrine In Psychiatric Illnesses
2021-09-01 13:00 - 14:00 (America/New_York) | MO
Home

Events

Proposed Roles Of Modulating Norepinephrine In Psychiatric Illnesses

Modulation of norepinephrine (NE) has become commonplace in understanding psychiatric illnesses and in therapeutic approaches. This presentation will investigate the complex overlap of monoamines and the role of NE in neuronal circuitry. The discussion will dive deep into the relationship between local NE concentration and receptor activation, in addition to the clinical utility of NE modulation by modifying other essential neurotransmitter systems.

Featuring

Miranda Fisher, PhD
Medical Science Liaison

Simon Kim, PharmD
Medical Science Liaison

Dennis Sholler, PhD (OPDC)
Senior Medical Science Liaison, CNS

Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Suicide & Black Americans: Statistics, Faith, & Contextual Competence
2021-09-10 12:00 - 13:00 (America/New_York) | MO
Home

Events

Suicide & Black Americans: Statistics, Faith, & Contextual Competence

September is National Suicide Prevention Month, with September 10th being World Suicide Prevention Day, and PsychU will be joining the awareness efforts. Mental health challenges exist across racial/ethnic and cultural lines, impacting individuals from all walks of life. Unfortunately, these challenges impact communities disproportionally. Specifically, it’s noted that suicide and suicidal ideations are common among Black Americans. Now is a critical time to address the mental health and wellness of our Black community. During this webinar Dr.’s Jonathan Singer and Sherry Molock will provide an overview of the suicide statistics and mental health in the Black community. They will then discuss the risks, protective factors, and barriers to mental wellness. Lastly, the speakers will provide approaches to suicide prevention and intervention strategies. Join in on this discussion and #BeThe1To help spread the word about actions we can all take to prevent suicide.

If you or someone you know is in crisis, please contact theSuicide Prevention Hotline / Lifeline at 1-800-273-TALK (8255), or text the Crisis Text Line at 741-741

Featuring

Jonathan Singer, PhD, LCSW
Esteemed author and scholar, with expertise in suicide prevention and social worker. He serves as Professor at Loyola University’s School of Social Work, is an emeritus president of the Association of Suicidology, founder & host of the Social Work podcast, as well as PsychU speaker & collaborator.

Sherry Molock, PhD, M.Div.
Associate Professor, Department of Psychological & Brain Sciences,
The George Washington University

Amica Simmons-Yon, PharmD, PhD
Senior Medical Science Liaison, Neuroscience Field Medical Affairs

Dr. Jonathan Singer and Dr. Sherry Molock are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Dr. Amica Simmons-Yon is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Jonathan Singer, PhD, LCSWJonathan Singer, PhD, LCSW, is an Associate Professor in the School of Social Work at Loyola University Chicago. Dr. Singer has had a long-standing interest in the role of technology in social work practice. He is the founder and host of the award-winning Social Work Podcast (www.socialworkpodcast.com), the first podcast by and for social workers. Dr. Singer is interested in the interpersonal mechanisms that protect against or contribute to youth suicidal risk within families; how and why parents access services for their suicidal children; and how to improve school responsiveness to youth suicide crises. Dr. Singer is a well-regarded, international speaker and his research has been featured in national and international media outlets. In the past, he served as the President of the American Association of Suicidology.

Sherry Molock, PhD, M.Div.Sherry Davis Molock, PhD, M.Div., is an Associate Professor in the Department of Psychological & Brain Sciences at The George Washington University in Washington, DC (https://psychology.columbian.gwu.edu/sherry-molock). She is an expert with over 20 years of experience researching, educating, and providing prevention strategies for suicide risk among the African & Black American communities. Dr. Molock currently teaches undergraduate and doctoral courses in the field of clinical psychology and conducts research on the prevention of suicide and HIV in African American adolescents and young adults. In addition, Dr. Molock is a founding pastor of the Beloved Community Church – United Church in Christ in Accokeek, Maryland where her ministry focuses on “family healing”.

Amica Simmons-Yon, PharmD, PhDMedical Science Liaison, Field Medical AffairsOtsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Technology In Mental Health: Role Of The Treatment Team
2021-09-14 12:00 - 13:00 (America/New_York) | MO
Home

Events

Technology in Mental Health: Role of the Treatment Team

Digital health technology can be used in a variety of settings to increase adherence, engage patients, and measure outcomes. Many providers are adopting digital health solutions to increase their ability to provide efficient and effective care to the patients they serve. In this webinar, Dr. Dan Karlin, MD and Dr. Jake Behrens, MD discuss the role of collaborative treatment teams and the integration of digital tools into comprehensive care strategies.

Featuring:

Daniel Karlin, MDChief Medical Officer, MindMed, New York, NY

Jake Behrens, MDCEO & Medical Director, Envision ADHD, Milwaukee, WI

Mark TaceloskyMedical Science Liaison

Featuring

Daniel Karlin, MD
Chief Medical Officer, MindMed, New York, NY

Jake Behrens, MD
CEO & Medical Director, Regional Director
Envision ADHD, Brightside Health

Mark Tacelosky, PharmD
Senior Medical Science Liaison

Daniel Karlin & Jake Behrens are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Mark Tacelosky is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Joint Virtual Event - Major Depressive Disorder In Chronic Kidney Disease
2021-09-14 12:00 - 13:00 (America/New_York) | MO
Home

Events

Major Depressive Disorder In Chronic Kidney Disease

This is a joint virtual live event for NephU & PsychU members in Maine, New Hampshire, Vermont, Rhode Island, Massachusetts, and Connecticut.

There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the impact of comorbid depression on CKD outcomes, and strategies for effective management of depression in CKD.

Featuring

Alyssa Peckham, PharmD, BCPP (OPDC)
Clinical & Scientific Liaison

Alf Carroll, MS, PA-C (he/him) (OPDC)
Clinical & Scientific Liaison, Nephrology

Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Do Inflammation and Metabolic Disturbances Metastasize to the Brain? Implications for Disease Modeling and Novel Approaches in Psychiatry
2021-09-20 12:00 - 13:00 (America/New_York) | MO
Home

Events

Do Inflammation and Metabolic Disturbances Metastasize to the Brain? Implications for Disease Modeling and Novel Approaches in Psychiatry

This is a Virtual Event for PsychU members in Florida.

During this presentation, Dante Durand, MD, MBA and Aneta Fornal, PharmD will discuss the effect of inflammation and metabolic disturbances on mood disorders.

The objectives of the presentation are to:

• Describe the importance of cognitive symptoms as psychiatric targets • Review immune and metabolic systems associated with cognitive deficits and mood disorders • Discuss innovative approaches that may target these symptoms

Featuring

Dante Durand, MD, MBA
Vice Chair of Clinical Services & Associate Professor, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine; Chief Medical Officer at Jackson Behavioral Health Hospital in Miami, FL.

Aneta Fornal, PharmD (OPDC)
Medical Science Liaison

Speaker Dante Durand, MD, MBA is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speakers Aneta Fornal, PharmD and Jacquelyn Canning, PharmD, BCPP are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Decriminalizing Mental Illness
2021-09-22 12:00 - 13:00 (America/New_York) | MO
Home

Events

Decriminalizing Mental Illness

This is a virtual event for PsychU members in Arizona, California, Florida, Iowa, Michigan, North Carolina, and Ohio.

U.S. correctional institutions, local courts, and police officers frequently encounter people with untreated mental health disorders. Once incarcerated, individuals with mental illness tend to stay longer in jail and upon release are at a higher risk to incarceration than those without mental illness. Many communities have developed strategies to redirect people with mental illnesses away from the criminal justice system. These approaches can have long-lasting benefits such as reduction in inappropriate arrests and incarcerations, recidivism rates, and costs.

In this webinar, Judge Steven Leifman and Justin Volpe will examine statistics and demographics of individuals in the criminal justice system with a focus on those with mental health disorders. The speakers will discuss the different types of jail diversion services available for individuals with a mental health disorder within the criminal justice system. Specifically, they will review an example of a successful jail diversion program – Eleventh Judicial Circuit Criminal Mental Health Project – and its positive outcomes. Lastly, the speakers will review available resources for caregivers and patients navigating the criminal justice system.

Featuring

Steven Leifman, JD
Associate Administrative Judge, Miami-Dade County Court – Criminal Division

Justin Volpe,
Certified Recovery Peer Specialist, Miami-Dade County’s 11th Judicial Criminal Mental Health Project Jail Diversion Program

Elizabeth DiNapoli, PhD (OPDC)
Senior Medical Science Liaison

Speakers Steven Leifman, JD and Justin Volpe are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Elizabeth DiNapoli, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - The Aftermath of Suicide: What Can Be Done & How Should We Talk About It?
2021-09-22 13:00 - 14:00 (America/New_York) | MO
Home

Events

This is a Virtual Event for PsychU members in Texas.

The presentation will focus on the impact of suicide on mental health. Upon reviewing the prevalence and suicide statistics in the U.S., the discussion will review how certain myths, media coverage, and language can give rise to misperceptions. Strategies to combat stigma and protect those at risk will be featured.

Featuring

Harry Croft, MD
Psychiatrist and medical educator in the San Antonio, TX area.

Dennis Pabis, PharmD, BCPP (OPDC)
Senior Medical Science Liaison

Speaker Harry Croft, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
Dennis Pabis, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Role of Pharmacogenetic Testing in Psychiatry
2021-10-06 13:00 - 14:00 (America/New_York) | MO
Home

Events

Role of Pharmacogenetic Testing in Psychiatry

This is a Virtual Event for PsychU members in Missouri, Oklahoma, and Kansas.

Pharmacogenetics allows for treatment customization based on an individual’s genetic profile. This presentation will explore the possible role of genetic information in psychiatry by cross-examining the potential utility and limitations of pharmacogenetic testing.

Featuring

Steven Stoner, PharmD
Associate Dean for Student Affairs/Clinical Professor, University of Missouri-Kansas City School of Pharmacy

Laura Anguiano, PhD (OPDC)
Senior Clinical & Scientific Liaison

Speaker Steven C. Stoner, PharmD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Laura Anguiano, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Addressing the Transition of Care For Patients with Schizophrenia: A Case Study Approach
2021-10-07 12:00 - 13:00 (America/New_York) | MO
Home

Events

Addressing the Transition of Care For Patients with Schizophrenia: A Case Study Approach

This is a Virtual Event for PsychU members in New York City, Upper/Lower Manhattan, and Rockland County, N.J.

In this presentation, the objectives are to:

Review current challenges faced by patients with schizophrenia during the transition from hospital discharge to the community care settingHighlight published data on outcomes related to patient relapse, outpatient visit attendance, rehospitalization and the value of clinical bridging strategiesReview interventions to assist in discharge planningDiscuss antipsychotic medications and adherence issues

Featuring

Michael Townsend, MA, LSW/LCSW
Deputy Chief Executive Officer, Gateway Counseling Center

Jehan Marino, PharmD, BCPP
Medical Science Director

Becky Wong, PharmD, MBA
Medical Science Director

Speakers Jehan Marino, PharmD, BCPP and Becky Wong, PharmD, MBA are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

LIVE EVENT - Cannabis: Potential Risks & Benefits in Mental Health
2021-10-07 18:30 - 20:30 (America/North_Dakota/New_Salem) | Eddie V’s Prime Seafood – Highland Park Room, 4023 Oak Lawn Ave, 100, Dallas, TX, 75219, United States
Home

Events

Cannabis: Potential Risks & Benefits in Mental Health

This is a Live Event for memebers of PsychU in Dallas, Texas.

The presentation will address the increasing relevance of cannabis in the U.S. and the importance for care providers to communicate with patients on cannabis use. The discussion will examine the changing U.S. regulatory landscape, detail the neurobiological effects of cannabis, and review the potential risk and benefits of cannabis in mental health.

Venue

Featuring

Joel Holiner, MD
Psychiatry Specialist with The Holiner Psychiatric Group.

Kimberly Lonergan, RN, MSN (OPDC)
Regional Medical Lead

Speaker Joel Holiner, MD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Kimberly Lonergan, RN, MSN is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Perspectives Of Schizophrenia Treatment Guidelines
2021-10-13 12:00 - 13:00 (America/New_York) | MO
Home

Events

Perspectives Of Schizophrenia Treatment Guidelines

Schizophrenia is a challenging diagnosis both domestically and across the world. Various treatment guidelines have been developed by key thought leaders to share perspectives on acute and long-term management of Schizophrenia. Join Jehan Marino, Senior Medical Science Liaison for Otsuka Pharmaceutical Development and Commercialization, as she moderates a robust discussion with Dr. Christoph Correll. Dr. Correll will provide his perspectives of schizophrenia guidelines development, with a focus on key similarities and differences.

Featuring

Christoph Correll, MD
Chair of the Department of Child and Adolescent Psychiatry, Psychosomatic Medicine and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany. Professor of Psychiatry at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, USA.

Jehan Marino, PharmD, BCPP
Medical Science Director

Christoph Correll, MD, is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.
Jehan Marino, PharmD, BCPP, is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

The Role Of The Pharmacist In The Treatment Of Depression
2021-10-19 12:00 - 13:00 (America/New_York) | MO
Home

Events

The Role Of The Pharmacist In The Treatment Of Depression

Depression is one of the most common psychiatric illnesses affecting approximately 8% of American adults in a given year. Despite the high prevalence of depression, it is often not adequately managed. Pharmacists are well placed to have a role in depression management across practice settings, complementing the role of general practitioners and psychiatric providers.

In this webinar, we will discuss the role of the pharmacist in the treatment of depression.

Featuring:

Megan Ehret, PharmD, MS, BCCPPsychU Pharmacist Corner Section Advisor ProfessorDepartment of Pharmacy Practice and ScienceUniversity of Maryland School of Pharmacy

Richard Silvia, PharmD, BCPPProfessorDepartment of Pharmacy Practice Massachusetts College of Pharmacy and Health Sciences

Aneta Fornal, PharmDSenior Clinical & Scientific Liaison, Otsuka Field Medical Affairs

Megan Ehret, PharmD, MS, BCCP Dr. Ehret is a graduate of the University of Toledo where she completed her BS and PharmD degrees, and she went on to complete a Psychiatric Pharmacy Residency at the Louis Stokes VAMC, under the direction of Matthew Fuller. She then completed a Psychopharmacology and Pharmacogenomics Fellowship at Nova Southeastern University, under the direction of Gary Levin. After training she received her initial faculty appointment at the University of Connecticut and gained tenure during her stay there. While at the University of Connecticut, Dr. Ehret served as the Vice-Chair of the IRB, Director of Practices for the Center for Correctional Health Networks, and a faculty member for Project: ECHO: Buprenorphine. Currently, her full-time role is a Professor at the University of Maryland School of Pharmacy with a practice site at The University of Maryland Mid Town Campus. Additionally, she also has the privilege of working with the State of Maryland Medicaid Program in evaluating antipsychotic use in the state. She is a Past-President of CPNP and is the current Section Editor for the Pharmacist Corner for PsychU. Dr. Ehret has numerous publications and book chapters describing psychotropic medication adherence and the role of pharmacogenomics in medication selection. Her current interests include psychotropic medication adherence and the advancement of the psychiatric pharmacist in practice.

Richard Silvia, PharmD, BCPP Dr. Silvia earned his Doctor of Pharmacy degree from the University of Rhode Island. Afterwards, he completed a two-year residency/fellowship in psychiatric pharmacy practice at the Institute of Living in Hartford, CT and affiliated with the University of Connecticut School of Pharmacy. He then joined the faculty of MCPHS University in 2001, where he is currently a Professor of Pharmacy Practice. Dr. Silvia maintains a practice site at the Codman Square Health Center, a federally-qualified community health center in Dorchester, MA. He maintains a busy collaborative practice in integrated behavioral health within the primary care clinics of the center. He is Board Certified in Psychiatric Pharmacotherapy (BCPP), and is active in the College of Psychiatric and Neurologic Pharmacists (CPNP) and American College of Clinical Pharmacy (ACCP). His research interests include measuring the effectiveness of clinical pharmacists in novel practice settings and studying the adverse effects observed with psychotropic medications and the appropriate management and treatment of these adverse effects.

Featuring

Megan Ehret, PharmD, MS, BCPP
Professor, Department of Pharmacy Practice & Science, University of Maryland School of Pharmacy

Richard Silvia, PharmD, BCPP
Professor, Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences

Aneta Fornal, PharmD (OPDC)
Medical Science Liaison

Dr. Megan Ehret and Dr. Richard Silvia are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Dr. Aneta Fornal is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Bipolar Disorder: Updates on Research and Clinical Outcomes
2021-10-19 13:00 - 14:00 (America/New_York) | MO
Home

Events

Bipolar Disorder: Updates on Research and Clinical Outcomes

This presentation details the multidimensional nature of bipolar disorder and highlights the wide spectrum of associated manic and depressive symptoms. The discussion will review the brain anatomical correlation of symptoms as well as the underlying pathophysiological theories. Furthermore, the impact of residual symptoms on clinical outcomes, on recurrence and cognitive deficits will be explored.

Featuring

Rodrigo Machado-Vieira, MD, PhD, MSc
Professor of Psychiatry & Behavioral Sciences & Director of the Experimental Therapeutics & Molecular Pathophysiology Program (ETP), Faillace Department of Psychiatry & Behavioral Sciences, UTHealth – Houston

Dennis Pabis, PharmD, BCPP (OPDC)
Senior Medical Science Liaison

Speaker Rodrigo Machado-Vieira, MD, PhD, MSc is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Dennis Pabis, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Mental Health Awareness: A Focus on Suicide and Stigma
2021-10-20 12:00 - 13:00 (America/New_York) | MO
Home

Events

Mental Health Awareness: A Focus on Suicide and Stigma

This is a Virtual Event for PsychU members in North Carolina and Virginia.

The presentation aims to raise mental health awareness on suicide. The discussion will review the multifaceted and dynamic factors that contribute to risk and explore prevention strategies focused on reducing stigma and discrimination.

Featuring

Kristen Nagy, PharmD, BCPS, BCPP
Clinical Pharmacy Coordinator-Psychiatry;
Assistant Professor-Sandra and Leon Levine Psychiatry Residency Program,
Atrium Health Behavioral Health, a facility of Carolinas Medical Center Charlotte

Amica Simmons-Yon, PharmD, PhD
Senior Medical Science Liaison, Neuroscience Field Medical Affairs

Speaker Amica Simmons-Yon is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Kristen Nagy, PharmD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Improving Chronic Disease Control by Bringing Medication Management Services to Patients
2021-10-21 12:00 - 13:00, 2021-10-21 15:00 - 16:00 (America/New_York) | MO
Home

Events

Improving Chronic Disease Control by Bringing Medication Management Services to Patients

This is a virtual event for PsychU members in Alaska, California, Colorado, Oregon, Utah, Washington, Wyoming, and New Jersey.

Medication-related problems cost the United States $290 billion per year in avoidable medical spending. In recognizing 2021 National Pharmacy Week, please join Drs. Bryan Archuleta, Simon Kim and Becky Wong for this virtual program where they will discuss the importance of Comprehensive Medication Management (CMM), explore the value of CMM, and describe what a CMM practice looks like and how it is implemented and sustained.

In this presentation, speakers will:

Explain the purpose and components of comprehensive medication management (CMM)Discuss the potential value of CMM and those who may benefit from itExplore what a CMM practice looks like, how CMM is implemented, and how it is sustained

Featuring

Becky Wong, PharmD, MBA
Medical Science Director

Bryan Archuleta, PharmD
Senior Long-Term Care Medical Science Liaison

Simon Kim, PharmD
Medical Science Liaison

Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.
